Isoproterenol-induced creatine kinase leakage in Langendorff-perfused rat heart associated with significant myocardial edema

Japanese Heart Journal

Volumn 39, Issue 4, 1998, Pages 513-525

  Odashiro, Keita ^a   Hiramatsu, Shin Ichi ^a   Maruyama, Toru ^a   Kaji, Yoshikazu ^a   Kanaya, Shozo ^b   Fujino, Takehiko ^b   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

cAMP dependent protein kinase; Creatine kinase; Myocardial edema; Sarcolemma; adrenoceptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; CEPHARANTHINE; CREATINE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; HEART EDEMA; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART PERFUSION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA; TEMPERATURE DEPENDENCE; TISSUE WATER; WATER PERMEABILITY;

EID: 0031872063     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.39.513     Document Type: Article

References (24)

1. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971, 50: 2614-25.
2. Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1978; 61: 1048-56.
3. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
4. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Intern Med 1986; 105: 221-33.
5. de Leiris J, Hearse DJ. Myocardial enzyme leakage as an indicator of cellular injury: principles and application. In: Dhalla NS, editor. Methods in Studying Cardiac Membranes, Vol. 1. Florida: CRC Press, 1984: 253-77.
6. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985; 17: 291-306.
7. The Lambeth conventions. Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988, 22: 447-55.
8. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967; 69: 696-705.
9. Hohorst HJ. L(+) lactate. Determination with lactic dehydrogenase and DPN. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press, 1963: 266-70.
10. Yano K, Maruyama T, Makino N, Matsui H, Yanaga T. Effects of amiloride on the mechanical, electrical and biochemical aspects of ischemia-reperfusion injury. Mol Cell Biochem 1993; 121: 75-83.
11. Mitani S, Hashimoto H, Matsui H, Toki Y, Okumura K, Ito T. Insulin as a determinant of cardiac but not skeletal muscle creatine kinase MB (abst). J Mol Cell Cardiol 1994; 26: CCXXIV.
12. Bernauer W. Digoxin induced release of creatine kinase from isolated guinea-pig hearts. NaunynSchmiedeberg's Arch 1979; 309: 83-8.
13. Sammel NL, Norris RM, Hughes CF, Johnson RN, Ashton NG, Elliott RL. Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol. Cardiovasc Res 1983; 17: 50-60.
14. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 1959; 67: 443-55.
15. Rona G, Chappel CI, Kahn DS. The significance of factors modifying the development of isoproterenol-induced myocardial necrosis. Am Heart J 1963; 66: 389-95.
16. Fleckenstein A, Janke J, Do'ring HJ, Pachinger O. Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. In: Bajusz E, Rona G, editors. Cardiomyopathies. Baltimore: University Park Press, 1973: 455-66.
17. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989; 65: 657-70.
18. Hakamata N, Hamada H, Ohsuzu F, Nakamura H. Cardiac-adrenergic signaling pathway alteration in isoproterenol-induced cardiac hypertrophy in male Sprague-Dawley rats. Jpn Heart J 1997; 38: 849-57.
19. Mak IT, Kramer JH, Freedman AM, Tse SYH, Weglicki WB. Oxygen radical-mediated injury of myocytes-protection by propranolol. J Mol Cell Cardiol 1990; 22: 687-95.
20. + pump current of single rat and guinea-pig cardiac cells. J Physiol (Lond) 1995; 484: 617-28.
21. Shattock MJ, Bers DM. Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol 1989; 256: C813-C822.
22. Liu X, Engelman RM, Agrawal HR, Das DK. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol 1991; 23: 1091-100.
23. Fujioka H, Yoshihara S, Tanaka T, et al. Enhancement of post-hypoxic contractile and metabolic recovery of perfused rat hearts by dl-propranorol: possible involvement of non-beta-receptor mediated activity. J Mol Cell Cardiol 1991; 23: 949-62.
24. Okumura K, Ogawa K, Satake T. Pretreatment with chlorpromaziue prevents phospholipid degradation and creatine kinase depletion in isoproterenol-induced myocardial damage in rats. J Cardiovasc Pharmacol 1983; 5: 983-8.